Neurology Minute

Neurology Minute

The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(1943)

Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke

Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke

Dr. Geoffrey Donnan discusses the main takeaways from his study on thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. Read his NEJM article here: https://www.nejm.org/doi/pd...

29 Jul 20192min

Continuum Pearls: Disease-Modifying Therapies in MS

Continuum Pearls: Disease-Modifying Therapies in MS

Dr. Robert H. Gross discusses disease-modifying therapies in MS in the third part of a three-part series. To learn more, read the article "Monitoring, Switching, and Stopping Multiple Sclerosis Diseas...

25 Jul 20191min

Continuum Pearls: Disease-Modifying Therapies in MS, pt. 2

Continuum Pearls: Disease-Modifying Therapies in MS, pt. 2

Dr. Robert H. Gross discusses disease-modifying therapies in MS in the second part of a three-part series. To learn more, read the article "Monitoring, Switching, and Stopping Multiple Sclerosis Disea...

24 Jul 20193min

Determining clinically meaningful decline in preclinical Alzheimer disease

Determining clinically meaningful decline in preclinical Alzheimer disease

Dr. Philip Insel provides the main findings of his paper on determining clinically meaningful decline in preclinical Alzheimer disease.

23 Jul 20191min

Targeting Huntington Expression in Patients with Huntington's Disease

Targeting Huntington Expression in Patients with Huntington's Disease

Dr. Sarah Tabrizi discusses the main findings of her study on targeting Huntington expression in patients with Huntington's Disease. Ready the May 6th article in NEJM: https://www.nejm.org/doi/full/10...

22 Jul 20191min

Continuum Pearls: Disease-Modifying Therapies in MS

Continuum Pearls: Disease-Modifying Therapies in MS

Dr. Robert H. Gross discusses disease-modifying therapies in MS in the first part of a three-part series. To learn more, read the article "Monitoring, Switching, and Stopping Multiple Sclerosis Diseas...

19 Jul 20192min

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial, pt. 2

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial, pt. 2

Prof. Gil Wolfe discusses who might and might not be good candidates for thymectomy for non-thymomatous myasthenia gravis in the second part of his interview with Dr. Ted Burns. Read the full study in...

17 Jul 20193min

The full spectrum of epilepsies from SUDEP in the North American SUDEP Registry

The full spectrum of epilepsies from SUDEP in the North American SUDEP Registry

Dr. Orrin Devinsky summarizes his paper on the full spectrum of epilepsies and the North American SUDEP Registry. Listen to this week's full podcast for the entire interview.

16 Jul 20192min

Populært innen Helse

fastlegen
lydartikler-fra-aftenposten
rss-gukild-johaug
hvordan-har-du-det-mann
psykodrama
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
foreldreradet
rss-garne-damer
rss-skravla-gar
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
morten-ramm-lar-kakla-ga-til-du-sovner
g-punktet
klimaks
rss-lopedrommen
rss-kunsten-a-leve
hjernesterk
rss-loping-for-nybegynnere
hverdagspsyken
sinnsyn